Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum

Inflammation

Volumn 31, Issue 1, 2008, Pages 24-35

  Lima, Rafael R ^a   Guimaraes Silva, Joanilson ^a   Oliveira, Jorge L ^a   Costa, Ana Maria R ^a   Souza Rodrigues, Renata D ^a   Dos Santos, Claudia D ^a   Picanço Diniz, Cristovam W ^a   Gomes Leal, Walace ^a,b  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Basal ganglia; Excitotoxicity; Macrophages; Neutrophils; White matter damage

Indexed keywords

ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN; MYELIN BASIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTOSIS; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DIFFUSE AXONAL INJURY; ELECTRON MICROSCOPY; EXCITOTOXICITY; HISTOPATHOLOGY; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MICROINJECTION; NEUROPATHOLOGY; NEUTROPHIL; NONHUMAN; RAT; WHITE MATTER;

ANIMALS; AXONS; CORPUS STRIATUM; EXCITATORY AMINO ACID AGONISTS; GLIOSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MALE; MYELIN SHEATH; N-METHYLASPARTATE; NEUTROPHILS; PERFUSION; RATS; RATS, WISTAR;

RATTUS;

EID: 39049117404     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-007-9046-y     Document Type: Article

References (49)

1. Mitsios, N., J. Gaffney, P. Kumar, J. Krupinski, S. Kumar, and M. Slevin. 2006. Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology 73:159-175.
2. Taylor, T. N., P. H. Davis, J. C. Torner, J. Holmes, J. W. Meyer, and M. F. Jacobson. 1996. Lifetime cost of stroke in the United States. Stroke 27:1459-1466.
3. Lo, E. H., T. Dalkara, and M.A. Moskowitz. 2003. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4:399-415.
4. Esiri, M. M. 2007. The interplay between inflammation and neurodegeneration in CNS disease. J. Neuroimmunol. 184:4-16.
5. Tator, C. H., and M. G. Fehlings. 1991. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75:15-26.
6. Yoles, E., and M. Schwartz. 1998. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp. Neurol. 153:1-7.
7. Matute, C., E. Alberdi, M. Domercq, M. V. Sanchez-Gomez, A. Perez-Samartin, A. Rodriguez-Antiguedad, and F. Perez-Cerda. 2007. Excitotoxic damage to white matter. J. Anat. 210:693-702.
8. Medana, I. M., and M. M. Esiri. 2003. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126:515-530.
9. Coleman, M., and V. Perry. 2002. Axon pathology in neurological disease: a neglected therapeutic target. Trends. Neurosci. 25:532-537.
10. Gomes-Leal, W., D. J. Corkill, and C. W. Picanco-Diniz. 2005. Systematic analysis of axonal damage and inflammatory response in different white matter tracts of acutely injured rat spinal cord. Brain. Res. 1066:57-70.
11. Blight, A. R. 1994. Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage. Neuroscience 60:263-273.
12. Popovich, P. G., Z. Guan, P. Wei, I. Huitinga, N. van Rooijen, and B. T. Stokes. 1999. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158:351-365.
13. Popovich, P. G., Z. Guan, V. McGaughy, L. Fisher, W. F. Hickey, and D. M. Basso. 2002. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 61:623-633.
14. Jones, T. B., E.E. McDaniel, and P.G. Popovich. 2005. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11:1223-1236.
15. Hamby, A. M., S. W. Suh, T. M. Kauppinen, and R. A. Swanson. 2007. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 38:632-636.
16. Rogove, A. D., and S. E. Tsirka. 1998. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr. Biol. 8:19-25.
17. Dommergues, M. A., F. Plaisant, C. Verney, and P. Gressens. 2003. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121:619-628.
18. Bolton, S. J., and V. H. Perry. 1998. Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp. Neurol. 154:231-240.
19. Mahapatra, R. K., M. J. Edwards, J. M. Schott, and K. P. Bhatia. 2004. Corticobasal degeneration. Lancet. Neurol. 3:736-743.
20. Robinson, A. P., T. M. White, and D. W. Mason. 1986. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 57:239-247.
21. Gomes-Leal, W., D. J. Corkill, M. A. Freire, C. W. Picanco-Diniz, and V. H. Perry. 2004. Astrocytosis, microglia activation, oligodendrocyte degeneration, and pyknosis following acute spinal cord injury. Exp. Neurol. 190:456-467.
22. Gentleman, S. M., M. J. Nash, C. J. Sweeting, D. I. Graham, and G. W. Roberts. 1993. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 160:139-144.
23. McKenzie, K. J., D. R. McLellan, S. M. Gentleman, W. L. Maxwell, T. A. Gennarelli, and D. I. Graham. 1996. Is beta-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol. 92:608-613.
24. Ayres, M. 2005. "Biostat 4.0." 4th ed. Sociedade Civil Mamirauá/MCT/CNPQ. Imprensa Oficial do Estado do Pará, Belém.
25. Schnell, L., S. Fearn, H. Klassen, M. E. Schwab, and V. H. Perry. 1999. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 11:3648-3658.
26. Irving, E. A., D. L. Bentley, and A. A. Parsons. 2001. Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat. Acta Neuropathol. 102:627-635.
27. Dos Santos, C. D., C. W. Picanco-Diniz, W. Gomes-Leal. 2007. Differential patterns of inflammatory response, axonal damage and myelin impairment following excitotoxic or ischemic damage to the trigeminal spinal nucleus of adult rats. Brain Res. DOI 10.1016/j.brainres.2007.07.037.
28. Carlson, S. L., M. E. Parrish, J. E. Springer, K. Doty, and L. Dossett. 1998. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151:77-88.
29. Tator, C. H., and I. Koyanagi. 1997. Vascular mechanisms in the pathophysiology of human spinal cord injury. J. Neurosurg. 86:483-492.
30. Popovich, P. G., and W. F. Hickey. 2001. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J. Neuropathol. Exp. Neurol. 60:676-685.
31. Lazarov-Spiegler, O., O. Rapalino, G. Agranov, and M. Schwartz. 1998. Restricted inflammatory reaction in the CNS: a key impediment to axonal regeneration? Mol. Med. Today 4:337-342.
32. Rapalino, O., O. Lazarov-Spiegler, E. Agranov, G. J. Velan, E. Yoles, M. Fraidakis, A. Solomon, R. Gepstein, A. Katz, M. Belkin, M. Hadani, and M. Schwartz. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4:814-821.
33. Knoller, N., G. Auerbach, V. Fulga, G. Zelig, J. Attias, R. Bakimer, J. B. Marder, E. Yoles, M. Belkin, M. Schwartz, and M. Hadani. 2005. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J. Neurosurg. Spine 3:173-181.
34. Schwartz, M., O. Butovsky, W. Bruck, and U. K. Hanisch. 2006. Microglial phenotype: is the commitment reversible? Trends. Neurosci. 29:68-74.
35. Anderson, C. M., and R. A. Swanson. 2000. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32:1-14.
36. Aschner, M. 1998. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19:269-281.
37. Aschner, M. 1998. Astrocytic functions and physiological reactions to injury: the potential to induce and/or exacerbate neuronal dysfunction-a forum position paper. Neurotoxicology 19:7-17; discussion 37-8.
38. Li, Y., J. Chen, C. L. Zhang, L. Wang, D. Lu, M. Katakowski, Q. Gao, L. H. Shen, J. Zhang, M. Lu, and M. Chopp. 2005. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49:407-417.
39. Galtrey, C. M., and J. W. Fawcett. 2007. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain. Res. Rev. 54:1-18.
40. Goda, M., M. Isono, M. Fujiki, and H. Kobayashi. 2002. Both MK801 and NBQX reduce the neuronal damage after impact-acceleration brain injury. J. Neurotrauma 19:1445-1456.
41. Hughes, P. M., D. C. Anthony, M. Ruddin, M. S. Botham, E. L. Rankine, M. Sablone, D. Baumann, A. K. Mir, and V. H. Perry. 2003. Focal lesions in the rat central nervous system induced by endothelin-1. J. Neuropathol. Exp. Neurol. 62:1276-1286.
42. Verkhratsky, A., and F. Kirchhoff. 2007. NMDA Receptors in glia. Neuroscientist 13:28-37.
43. Karadottir, R., P. Cavelier, L. H. Bergersen, and D. Attwell. 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438:1162-1166.
44. Li, S., and P. K. Stys. 2001. Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter. Neuroscience 107:675-683.
45. Stys, P. K. 2005. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 233:3-13.
46. Schabitz, W. R., F. Li, and M. Fisher. 2000. The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke 31:1709-1714.
47. Matute, C. 2006. Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends. Mol. Med. 12:289-292.
48. Kanellopoulos, G. K., X. M. Xu, C. Y. Hsu, X. Lu, T. M. Sundt, and N. T. Kouchoukos. 2000. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke 31:1945-1952.
49. Frost, S. B., S. Barbay, M. L. Mumert, A. M. Stowe, and R. J. Nudo. 2006. An animal model of capsular infarct: endothelin-1 injections in the rat. Behav. Brain. Res. 169:206-211.